Shopping Cart 0
Cart Subtotal
AED 0

TheraDiag SA (ALTER) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Theradiag SA (Theradiag), formerly Biomedical Diagnostics SA, is a biotechnology company that develops, manufactures, and markets vitro diagnostic products. The company offers product for the diagnostics of auto-immune diseases, allergies and infectious diseases. It develops product panels for diagnosing autoimmune diseases, allergies, and infectious diseases. Theradiag provides tests using techniques and automatic devices and solutions for high-speed diagnostics. The company also offers multi-parametric monitoring system for treatment of autoimmune diseases by anti-TNF. It provides in-vitro diagnostic products in the fields of auto-immunity, allergies, infectious diseases and, more recently, oncology and molecular biology. The company serves autoimmune disease diagnostic markets. Theradiag is headquartered in Paris, France.

TheraDiag SA (ALTER)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

TheraDiag SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

TheraDiag SA, Medical Equipment Deals By Type, 2012 to YTD 2018 7

TheraDiag SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

TheraDiag SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

TheraDiag SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

TheraDiag SA, Medical Equipment, Deal Details 11

Partnerships 11

Miraca Life Sciences Enters into Licensing Agreement with Theradiag 11

TheraDiag Enters into Agreement with Biogaran 12

Theradiag Enters into Distribution Agreement with HOB Biotech 13

HOB Biotech Enters into Distribution Agreement with Theradiag 14

TheraDiag Enters into Co-Development Agreement with Unicancer and Bordeaux University 15

Theradiag Enters Into Co-Development Agreement With CNRS, IGMM And University of Montpellier 16

TheraDiag Enters Into Distribution Agreement With Luminex For xTAG RVP And xTAG GPP 17

TheraDiag Enters Into Co-Development Agreement With Regional Cancer Institute of Montpellier 18

TheraDiag Enters Into Agreement With Splicos And French National Center for Research 19

Theradiag Enters Into Co-Development Agreement With Sebia For New Diagnostic Kit 20

Equity Offering 21

TheraDiag Raises USD4.5 Million in Private Placement of Shares 21

TheraDiag Raises USD2.78 Million in Private Placement of Shares 22

TheraDiag Raises Funds in IPO of Shares 23

TheraDiag SA-Key Competitors 24

TheraDiag SA-Key Employees 25

TheraDiag SA-Locations And Subsidiaries 26

Head Office 26

Other Locations & Subsidiaries 26

Recent Developments 27

Strategy And Business Planning 27

Dec 19, 2017: THERADIAG provides an update on Prestizia and its partnership with HOB Biotech 27

Financial Announcements 28

Sep 19, 2018: Theradiag: 2018 interim results and business update 28

Apr 10, 2018: Theradiag reports its 2017 annual results and sales for first quarter 2018 30

Feb 20, 2018: Theradiag Announces 2017 Annual Sales and Cash Flow at End 2017 32

Oct 26, 2017: Theradiag: Revenues at the end of September 30, 2017 33

Sep 19, 2017: Theradiag: Results and activity for the first half of 2017 Continued improvement in results 34

Jul 25, 2017: Theradiag: Further Strong Sales Growth in the First Half of 2017: +9% 36

Apr 27, 2017: THERADIAG Announces First-quarter 2017 Revenues 37

Apr 27, 2017: Theradiag: First-Quarter 2017 Revenues 38

Mar 01, 2017: THERADIAG: Full-year 2016 results 39

Corporate Communications 41

Oct 09, 2018: Evolution of Theradiag's governance 41

Mar 01, 2017: Appointment of Dominique Costantini and Dominique Takizawa to Theradiag's Board of Directors 42

Legal and Regulatory 43

Jan 19, 2018: Miraca Life Sciences, Theradiag's partner in the USA, becomes Inform Diagnostics 43

Product News 44

Mar 28, 2017: Sixth test in Theradiag's monitoring range launched in the USA 44

Appendix 45

Methodology 45

About GlobalData 45

Contact Us 45

Disclaimer 45


List Of Figure

List of Figures

TheraDiag SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

TheraDiag SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

TheraDiag SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

TheraDiag SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

TheraDiag SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

TheraDiag SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

TheraDiag SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

TheraDiag SA, Medical Equipment, Deals by Market, 2012 to YTD 2018 9


List Of Table

List of Tables

TheraDiag SA, Medical Equipment, Key Facts, 2017 2

TheraDiag SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

TheraDiag SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

TheraDiag SA, Medical Equipment Deals By Type, 2012 to YTD 2018 7

TheraDiag SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

TheraDiag SA, Deals By Market, 2012 to YTD 2018 9

TheraDiag SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Miraca Life Sciences Enters into Licensing Agreement with Theradiag 11

TheraDiag Enters into Agreement with Biogaran 12

Theradiag Enters into Distribution Agreement with HOB Biotech 13

HOB Biotech Enters into Distribution Agreement with Theradiag 14

TheraDiag Enters into Co-Development Agreement with Unicancer and Bordeaux University 15

Theradiag Enters Into Co-Development Agreement With CNRS, IGMM And University of Montpellier 16

TheraDiag Enters Into Distribution Agreement With Luminex For xTAG RVP And xTAG GPP 17

TheraDiag Enters Into Co-Development Agreement With Regional Cancer Institute of Montpellier 18

TheraDiag Enters Into Agreement With Splicos And French National Center for Research 19

Theradiag Enters Into Co-Development Agreement With Sebia For New Diagnostic Kit 20

TheraDiag Raises USD4.5 Million in Private Placement of Shares 21

TheraDiag Raises USD2.78 Million in Private Placement of Shares 22

TheraDiag Raises Funds in IPO of Shares 23

TheraDiag SA, Key Competitors 24

TheraDiag SA, Key Employees 25

TheraDiag SA, Subsidiaries 26

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

TheraDiag SA, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

Theradiag SA (Theradiag), formerly Biomedical Diagnostics SA, is a biotechnology company that develops, manufactures, and markets vitro diagnostic products. The company offers product for the diagnostics of auto-immune diseases, allergies and infectious diseases. It develops product panels for diagnosing autoimmune diseases, allergies, and infectious diseases. Theradiag provides tests using techniques and automatic devices and solutions for high-speed diagnostics. The company also offers multi-parametric monitoring system for treatment of autoimmune diseases by anti-TNF. It provides in-vitro diagnostic products in the fields of auto-immunity, allergies, infectious diseases and, more recently, oncology and molecular biology. The company serves autoimmune disease diagnostic markets. Theradiag is headquartered in Paris, France.

TheraDiag SA (ALTER)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

TheraDiag SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

TheraDiag SA, Medical Equipment Deals By Type, 2012 to YTD 2018 7

TheraDiag SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

TheraDiag SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

TheraDiag SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

TheraDiag SA, Medical Equipment, Deal Details 11

Partnerships 11

Miraca Life Sciences Enters into Licensing Agreement with Theradiag 11

TheraDiag Enters into Agreement with Biogaran 12

Theradiag Enters into Distribution Agreement with HOB Biotech 13

HOB Biotech Enters into Distribution Agreement with Theradiag 14

TheraDiag Enters into Co-Development Agreement with Unicancer and Bordeaux University 15

Theradiag Enters Into Co-Development Agreement With CNRS, IGMM And University of Montpellier 16

TheraDiag Enters Into Distribution Agreement With Luminex For xTAG RVP And xTAG GPP 17

TheraDiag Enters Into Co-Development Agreement With Regional Cancer Institute of Montpellier 18

TheraDiag Enters Into Agreement With Splicos And French National Center for Research 19

Theradiag Enters Into Co-Development Agreement With Sebia For New Diagnostic Kit 20

Equity Offering 21

TheraDiag Raises USD4.5 Million in Private Placement of Shares 21

TheraDiag Raises USD2.78 Million in Private Placement of Shares 22

TheraDiag Raises Funds in IPO of Shares 23

TheraDiag SA-Key Competitors 24

TheraDiag SA-Key Employees 25

TheraDiag SA-Locations And Subsidiaries 26

Head Office 26

Other Locations & Subsidiaries 26

Recent Developments 27

Strategy And Business Planning 27

Dec 19, 2017: THERADIAG provides an update on Prestizia and its partnership with HOB Biotech 27

Financial Announcements 28

Sep 19, 2018: Theradiag: 2018 interim results and business update 28

Apr 10, 2018: Theradiag reports its 2017 annual results and sales for first quarter 2018 30

Feb 20, 2018: Theradiag Announces 2017 Annual Sales and Cash Flow at End 2017 32

Oct 26, 2017: Theradiag: Revenues at the end of September 30, 2017 33

Sep 19, 2017: Theradiag: Results and activity for the first half of 2017 Continued improvement in results 34

Jul 25, 2017: Theradiag: Further Strong Sales Growth in the First Half of 2017: +9% 36

Apr 27, 2017: THERADIAG Announces First-quarter 2017 Revenues 37

Apr 27, 2017: Theradiag: First-Quarter 2017 Revenues 38

Mar 01, 2017: THERADIAG: Full-year 2016 results 39

Corporate Communications 41

Oct 09, 2018: Evolution of Theradiag's governance 41

Mar 01, 2017: Appointment of Dominique Costantini and Dominique Takizawa to Theradiag's Board of Directors 42

Legal and Regulatory 43

Jan 19, 2018: Miraca Life Sciences, Theradiag's partner in the USA, becomes Inform Diagnostics 43

Product News 44

Mar 28, 2017: Sixth test in Theradiag's monitoring range launched in the USA 44

Appendix 45

Methodology 45

About GlobalData 45

Contact Us 45

Disclaimer 45


List Of Figure

List of Figures

TheraDiag SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

TheraDiag SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

TheraDiag SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

TheraDiag SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

TheraDiag SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

TheraDiag SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

TheraDiag SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

TheraDiag SA, Medical Equipment, Deals by Market, 2012 to YTD 2018 9


List Of Table

List of Tables

TheraDiag SA, Medical Equipment, Key Facts, 2017 2

TheraDiag SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

TheraDiag SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

TheraDiag SA, Medical Equipment Deals By Type, 2012 to YTD 2018 7

TheraDiag SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

TheraDiag SA, Deals By Market, 2012 to YTD 2018 9

TheraDiag SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Miraca Life Sciences Enters into Licensing Agreement with Theradiag 11

TheraDiag Enters into Agreement with Biogaran 12

Theradiag Enters into Distribution Agreement with HOB Biotech 13

HOB Biotech Enters into Distribution Agreement with Theradiag 14

TheraDiag Enters into Co-Development Agreement with Unicancer and Bordeaux University 15

Theradiag Enters Into Co-Development Agreement With CNRS, IGMM And University of Montpellier 16

TheraDiag Enters Into Distribution Agreement With Luminex For xTAG RVP And xTAG GPP 17

TheraDiag Enters Into Co-Development Agreement With Regional Cancer Institute of Montpellier 18

TheraDiag Enters Into Agreement With Splicos And French National Center for Research 19

Theradiag Enters Into Co-Development Agreement With Sebia For New Diagnostic Kit 20

TheraDiag Raises USD4.5 Million in Private Placement of Shares 21

TheraDiag Raises USD2.78 Million in Private Placement of Shares 22

TheraDiag Raises Funds in IPO of Shares 23

TheraDiag SA, Key Competitors 24

TheraDiag SA, Key Employees 25

TheraDiag SA, Subsidiaries 26

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

TheraDiag SA, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.